Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.45M
8 trades · 6 insiders
Net · 90d
$-1.45M
Insiders on file
15
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kreitzer Anatol | Chief Discovery Officer | 21 | $0 | $2.88M | 2026-10-15 |
| Foff Erin Pennock | Chief Medical Officer | 32 | $0 | $3.50M | 2026-10-15 |
| Hanson Kristopher | General Counsel | 30 | $0 | $1.92M | 2026-10-15 |
| Lillie James Woodruff | Chief Scientific Officer | 31 | $0 | $2.93M | 2026-10-15 |
| GILLIS JONATHAN | CAO and Interim CFO | 27 | $0 | $3.64M | 2026-10-15 |
| Kroeger Christopher A. | Chief Executive Officer, Director | 41 | $0 | $13.14M | 2026-10-15 |
| Cox Troy | Director | 4 | $297.4K | $0 | 2026-07-28 |
| Luneborg Nanna Liebach | Director | 2 | $0 | $0 | 2026-06-23 |
| Garnett Timothy John | Director | 5 | $252.7K | $0 | 2026-06-23 |
| Walker Maria C | Director | 4 | $0 | $0 | 2026-06-23 |
| Pavlov George | Director | 5 | $441.2K | $0 | 2026-06-23 |
| Babler Martin | Director | 2 | $0 | $0 | 2026-06-23 |
| Setia Vishwas | Chief Financial Officer | 16 | $0 | $1.10M | 2026-05-06 |
| Malenka Robert C. | Director | 18 | $0 | $1.60M | 2026-04-15 |
| Novo Holdings A/S | 10% Owner | 4 | $16.20M | $0 | 2025-10-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-10-15 | 2026-10-16 | 11,513 | $8.08 | $93.0K | 198,597 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer, Dir | S Sale | 2026-10-15 | 2026-10-16 | 73,691 | $8.08 | $595.4K | 1,195,909 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-10-15 | 2026-10-16 | 12,248 | $7.84 | $96.0K | 168,678 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-10-15 | 2026-10-16 | 9,020 | $8.08 | $72.9K | 128,024 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-10-15 | 2026-10-16 | 10,167 | $8.08 | $82.1K | 142,315 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-10-15 | 2026-10-16 | 15,355 | $8.08 | $124.1K | 296,906 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-09-16 | 2026-09-18 | 16,509 | $11.67 | $192.7K | 137,044 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-09-16 | 2026-09-18 | 16,509 | $11.67 | $192.7K | 137,044 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 93,955 | — | $0 | 93,955 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 54,240 | — | $0 | 54,240 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award deriv | 2026-08-17 | 2026-08-19 | 31,395 | — | $0 | 31,395 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 31,395 | — | $0 | 31,395 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award deriv | 2026-08-17 | 2026-08-19 | 2,813 | — | $0 | 2,813 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award deriv | 2026-08-17 | 2026-08-19 | 24,455 | — | $0 | 24,455 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 24,455 | — | $0 | 24,455 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | A Award | 2026-08-17 | 2026-08-19 | 23,145 | — | $0 | 1,269,600 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award | 2026-08-17 | 2026-08-19 | 13,360 | — | $0 | 312,261 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award | 2026-08-17 | 2026-08-19 | 7,730 | — | $0 | 153,553 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award | 2026-08-17 | 2026-08-19 | 7,730 | — | $0 | 210,110 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award | 2026-08-17 | 2026-08-19 | 2,222 | — | $0 | 152,482 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award | 2026-08-17 | 2026-08-19 | 6,020 | — | $0 | 150,260 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award | 2026-08-17 | 2026-08-19 | 6,020 | — | $0 | 180,926 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 31,395 | — | $0 | 31,395 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award | 2026-08-17 | 2026-08-19 | 7,730 | — | $0 | 210,110 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer, Dir | A Award deriv | 2026-08-17 | 2026-08-19 | 93,955 | — | $0 | 93,955 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer, Dir | A Award | 2026-08-17 | 2026-08-19 | 23,145 | — | $0 | 1,269,600 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 24,455 | — | $0 | 24,455 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award | 2026-08-17 | 2026-08-19 | 6,020 | — | $0 | 180,926 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award deriv | 2026-08-17 | 2026-08-19 | 31,395 | — | $0 | 31,395 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award | 2026-08-17 | 2026-08-19 | 7,730 | — | $0 | 153,553 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award deriv | 2026-08-17 | 2026-08-19 | 2,813 | — | $0 | 2,813 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award deriv | 2026-08-17 | 2026-08-19 | 24,455 | — | $0 | 24,455 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award | 2026-08-17 | 2026-08-19 | 2,222 | — | $0 | 152,482 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | A Award | 2026-08-17 | 2026-08-19 | 6,020 | — | $0 | 150,260 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award deriv | 2026-08-17 | 2026-08-19 | 54,240 | — | $0 | 54,240 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award | 2026-08-17 | 2026-08-19 | 13,360 | — | $0 | 312,261 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-08-03 | 2026-08-04 | 22,082 | $12.54 | $276.9K | 202,380 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-08-03 | 2026-08-04 | 22,082 | $12.54 | $276.9K | 202,380 | SEC↗ |
| Cox Troy | Director | P Buy | 2026-07-28 | 2026-07-28 | 15,620 | $9.52 | $148.7K | 15,620 | SEC↗ |
| Cox Troy | Director | P Buy | 2026-07-28 | 2026-07-28 | 15,620 | $9.52 | $148.7K | 15,620 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-17 | 2026-07-17 | 3,656 | $37.90 | $138.6K | 298,901 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-17 | 2026-07-17 | 1,130 | $37.90 | $42.8K | 145,823 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-17 | 2026-07-17 | 2,077 | $37.90 | $78.7K | 224,462 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-17 | 2026-07-17 | 16,779 | $37.90 | $635.9K | 1,246,455 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-17 | 2026-07-20 | 2,833 | $37.05 | $105.0K | 189,246 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-17 | 2026-07-20 | 14,140 | $37.70 | $533.1K | 175,106 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-17 | 2026-07-20 | 200 | $38.39 | $7.7K | 174,906 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-17 | 2026-07-20 | 900 | $38.17 | $34.4K | 144,240 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-17 | 2026-07-20 | 600 | $36.51 | $21.9K | 162,109 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-17 | 2026-07-20 | 16,969 | $37.61 | $638.2K | 145,140 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-16 | 2026-07-17 | 9,163 | $36.46 | $334.1K | 308,441 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-16 | 2026-07-17 | 5,865 | $37.26 | $218.5K | 302,576 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-16 | 2026-07-17 | 19 | $37.96 | $721 | 302,557 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-16 | 2026-07-17 | 11 | $37.96 | $418 | 146,953 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-16 | 2026-07-17 | 4,776 | $36.45 | $174.1K | 150,295 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-16 | 2026-07-17 | 3,331 | $37.26 | $124.1K | 146,964 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-16 | 2026-07-17 | 5,009 | $36.45 | $182.6K | 230,077 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-16 | 2026-07-17 | 3,526 | $37.26 | $131.4K | 226,551 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-16 | 2026-07-17 | 12 | $37.96 | $456 | 226,539 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-16 | 2026-07-17 | 40,899 | $36.46 | $1.49M | 1,291,417 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-16 | 2026-07-17 | 92 | $37.96 | $3.5K | 1,263,234 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-16 | 2026-07-17 | 28,091 | $37.26 | $1.05M | 1,263,326 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-16 | 2026-07-20 | 7,464 | $36.66 | $273.6K | 193,671 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-16 | 2026-07-20 | 1,592 | $37.44 | $59.6K | 192,079 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-16 | 2026-07-20 | 1,476 | $37.44 | $55.3K | 162,709 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-16 | 2026-07-20 | 6,979 | $36.66 | $255.9K | 164,185 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-15 | 2026-07-17 | 18 | $37.54 | $676 | 317,604 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-15 | 2026-07-17 | 7,155 | $36.16 | $258.7K | 338,904 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-15 | 2026-07-17 | 7,845 | $37.04 | $290.6K | 331,059 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-15 | 2026-07-17 | 8,972 | $36.99 | $331.9K | 317,622 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-07-15 | 2026-07-17 | 4,465 | $36.00 | $160.7K | 326,594 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-15 | 2026-07-17 | 10 | $37.54 | $375 | 155,071 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-15 | 2026-07-17 | 2,147 | $36.00 | $77.3K | 160,184 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-07-15 | 2026-07-17 | 5,103 | $36.99 | $188.8K | 155,081 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-15 | 2026-07-17 | 2,238 | $36.00 | $80.6K | 240,491 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-15 | 2026-07-17 | 12 | $37.54 | $450 | 235,086 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-07-15 | 2026-07-17 | 5,393 | $36.99 | $199.5K | 235,098 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-15 | 2026-07-17 | 90 | $37.54 | $3.4K | 1,332,316 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-15 | 2026-07-17 | 42,738 | $36.99 | $1.58M | 1,332,406 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-07-15 | 2026-07-17 | 18,950 | $36.00 | $682.2K | 1,375,144 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-15 | 2026-07-20 | 5,545 | $36.13 | $200.3K | 205,645 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-07-15 | 2026-07-20 | 4,510 | $36.94 | $166.6K | 201,135 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-15 | 2026-07-20 | 4,699 | $36.94 | $173.6K | 171,164 | SEC↗ |
| GILLIS JONATHAN | CAO and Interim CFO | S Sale | 2026-07-15 | 2026-07-20 | 5,356 | $36.13 | $193.5K | 175,863 | SEC↗ |
| Walker Maria C | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 14,902 | — | $0 | 14,902 | SEC↗ |
| Pavlov George | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 14,902 | — | $0 | 14,902 | SEC↗ |
| Luneborg Nanna Liebach | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 14,902 | — | $0 | 14,902 | SEC↗ |
| Garnett Timothy John | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 14,902 | — | $0 | 14,902 | SEC↗ |
| Babler Martin | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 29,804 | — | $0 | 29,804 | SEC↗ |
| Cox Troy | Director | A Award deriv | 2026-06-23 | 2026-06-25 | 29,804 | — | $0 | 29,804 | SEC↗ |
| Walker Maria C | Director | A Award | 2026-06-23 | 2026-06-25 | 3,932 | — | $0 | 62,703 | SEC↗ |
| Pavlov George | Director | A Award | 2026-06-23 | 2026-06-25 | 3,932 | — | $0 | 28,932 | SEC↗ |
| Luneborg Nanna Liebach | Director | A Award | 2026-06-23 | 2026-06-25 | 3,932 | — | $0 | 3,932 | SEC↗ |
| Garnett Timothy John | Director | A Award | 2026-06-23 | 2026-06-25 | 3,932 | — | $0 | 53,457 | SEC↗ |
| Babler Martin | Director | A Award | 2026-06-23 | 2026-06-25 | 7,864 | — | $0 | 7,864 | SEC↗ |
| Cox Troy | Director | A Award | 2026-06-23 | 2026-06-25 | 7,864 | — | $0 | 7,864 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-18 | 2026-05-18 | 118,037 | $27.19 | $3.21M | 1,394,292 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-18 | 2026-05-18 | 198 | $28.15 | $5.6K | 1,394,094 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-11 | 2026-05-11 | 342 | $27.57 | $9.4K | 1,525,967 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-11 | 2026-05-11 | 5,890 | $30.56 | $180.0K | 1,512,329 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-11 | 2026-05-11 | 6,871 | $30.04 | $206.4K | 1,518,219 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-11 | 2026-05-11 | 877 | $28.70 | $25.2K | 1,525,090 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-11 | 2026-05-11 | 284 | $27.61 | $7.8K | 175,964 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-11 | 2026-05-11 | 846 | $28.70 | $24.3K | 175,118 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-11 | 2026-05-11 | 6,979 | $30.04 | $209.6K | 168,139 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-11 | 2026-05-11 | 5,808 | $30.56 | $177.5K | 162,331 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-08 | 2026-05-11 | 3,205 | $29.20 | $93.6K | 1,526,309 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-08 | 2026-05-11 | 29,624 | $27.48 | $814.1K | 1,531,096 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-08 | 2026-05-11 | 1,582 | $28.56 | $45.2K | 1,529,514 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-07 | 2026-05-11 | 721 | $28.28 | $20.4K | 242,729 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-07 | 2026-05-11 | 117 | $29.10 | $3.4K | 346,059 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-07 | 2026-05-11 | 4,321 | $28.52 | $123.2K | 346,176 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-07 | 2026-05-11 | 14,880 | $28.47 | $423.6K | 1,565,940 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-07 | 2026-05-11 | 5,220 | $29.15 | $152.2K | 1,560,720 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-06 | 2026-05-06 | 8,098 | $28.04 | $227.1K | 1,596,423 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-06 | 2026-05-06 | 15,603 | $29.13 | $454.5K | 1,580,820 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-06 | 2026-05-06 | 8,390 | $28.04 | $235.3K | 259,871 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-06 | 2026-05-06 | 16,421 | $29.13 | $478.3K | 243,450 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-06 | 15,900 | $29.13 | $463.2K | 350,497 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-06 | 8,152 | $28.04 | $228.6K | 366,397 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-06 | 2,068 | $29.07 | $60.1K | 356,256 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-06 | 2026-05-06 | 8,496 | $28.04 | $238.2K | 358,324 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-05 | 2026-05-06 | 928 | $29.00 | $26.9K | 1,604,521 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-05 | 2026-05-06 | 9,544 | $28.12 | $268.4K | 1,605,449 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-05 | 2026-05-06 | 10,132 | $28.12 | $284.9K | 269,224 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-05 | 2026-05-06 | 963 | $29.00 | $27.9K | 268,261 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-05 | 2026-05-06 | 931 | $29.00 | $27.0K | 374,549 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-05 | 2026-05-06 | 9,645 | $28.12 | $271.2K | 375,480 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-05 | 2026-05-06 | 968 | $29.00 | $28.1K | 366,820 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-05 | 2026-05-06 | 9,935 | $28.12 | $279.4K | 367,788 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-04 | 2026-05-06 | 5,427 | $28.37 | $154.0K | 1,616,001 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-04 | 2026-05-06 | 697 | $30.08 | $21.0K | 1,614,993 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-04 | 2026-05-06 | 9,136 | $27.50 | $251.2K | 1,621,428 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-05-04 | 2026-05-06 | 311 | $29.56 | $9.2K | 1,615,690 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-04 | 2026-05-06 | 683 | $30.08 | $20.5K | 176,248 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-04 | 2026-05-06 | 9,030 | $27.50 | $248.3K | 181,135 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-04 | 2026-05-06 | 3,908 | $28.29 | $110.6K | 177,227 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-05-04 | 2026-05-06 | 296 | $29.56 | $8.7K | 176,931 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-04 | 2026-05-06 | 705 | $30.08 | $21.2K | 279,356 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-04 | 2026-05-06 | 320 | $29.56 | $9.5K | 280,061 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-04 | 2026-05-06 | 9,250 | $27.50 | $254.4K | 285,907 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-05-04 | 2026-05-06 | 5,526 | $28.37 | $156.8K | 280,381 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-04 | 2026-05-06 | 700 | $30.08 | $21.1K | 385,125 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-04 | 2026-05-06 | 312 | $29.56 | $9.2K | 385,825 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-04 | 2026-05-06 | 5,460 | $28.37 | $154.9K | 386,137 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-05-04 | 2026-05-06 | 9,180 | $27.50 | $252.4K | 391,597 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-04 | 2026-05-06 | 787 | $30.12 | $23.7K | 377,723 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-04 | 2026-05-06 | 325 | $29.56 | $9.6K | 378,510 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-04 | 2026-05-06 | 8,989 | $28.28 | $254.2K | 378,835 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-05-04 | 2026-05-06 | 4,803 | $27.36 | $131.4K | 387,824 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | S Sale | 2026-04-28 | 2026-04-29 | 17,235 | $30.33 | $522.7K | 181,919 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | S Sale | 2026-04-28 | 2026-04-29 | 700 | $30.83 | $21.6K | 181,219 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-04-27 | 2026-04-29 | 8,346 | $28.96 | $241.7K | 248,266 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-04-27 | 2026-04-29 | 29,255 | $29.63 | $866.8K | 219,011 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-04-27 | 2026-04-29 | 7,821 | $30.50 | $238.5K | 211,190 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | S Sale | 2026-04-27 | 2026-04-29 | 29,623 | $29.60 | $876.8K | 213,517 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | S Sale | 2026-04-27 | 2026-04-29 | 14,363 | $30.46 | $437.5K | 199,154 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | S Sale | 2026-04-27 | 2026-04-29 | 7,914 | $28.94 | $229.0K | 243,140 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-04-16 | 2026-04-17 | 7,575 | $27.49 | $208.2K | 1,630,564 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-04-16 | 2026-04-17 | 2,477 | $27.01 | $66.9K | 1,638,139 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-04-16 | 2026-04-17 | 288 | $27.01 | $7.8K | 401,658 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-04-16 | 2026-04-17 | 881 | $27.49 | $24.2K | 400,777 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-04-16 | 2026-04-17 | 686 | $27.01 | $18.5K | 297,254 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-04-16 | 2026-04-17 | 2,097 | $27.49 | $57.6K | 295,157 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-04-16 | 2026-04-17 | 87 | $27.49 | $2.4K | 392,627 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-04-16 | 2026-04-17 | 29 | $27.01 | $783 | 392,714 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-04-16 | 2026-04-17 | 225 | $27.49 | $6.2K | 190,165 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-04-16 | 2026-04-17 | 73 | $27.01 | $2.0K | 190,390 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-04-15 | 2026-04-17 | 8,593 | $26.90 | $231.2K | 316,466 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | S Sale | 2026-04-15 | 2026-04-17 | 9,135 | $26.93 | $246.0K | 1,640,616 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | S Sale | 2026-04-15 | 2026-04-17 | 2,044 | $26.84 | $54.9K | 401,946 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | S Sale | 2026-04-15 | 2026-04-17 | 1,730 | $26.82 | $46.4K | 297,940 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | S Sale | 2026-04-15 | 2026-04-17 | 2,806 | $26.87 | $75.4K | 392,743 | SEC↗ |
| Hanson Kristopher | General Counsel | S Sale | 2026-04-15 | 2026-04-17 | 1,529 | $26.80 | $41.0K | 190,463 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | S Sale | 2026-04-15 | 2026-04-17 | 3,590 | $26.61 | $95.5K | 251,054 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | S Sale | 2026-04-15 | 2026-04-17 | 3,316 | $26.61 | $88.2K | 256,612 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-24 | 2026-02-24 | 736 | $18.15 | $13.4K | 325,059 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-23 | 2026-02-24 | 476 | $19.06 | $9.1K | 325,795 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-23 | 2026-02-24 | 10,788 | $18.39 | $198.4K | 326,271 | SEC↗ |
| Pavlov George | Director | P Buy | 2026-02-20 | 2026-02-20 | 9,920 | $17.86 | $177.2K | 25,000 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-20 | 2026-02-24 | 2,195 | $18.03 | $39.6K | 337,059 | SEC↗ |
| Pavlov George | Director | P Buy | 2026-02-19 | 2026-02-20 | 4,422 | $17.57 | $77.7K | 15,080 | SEC↗ |
| Pavlov George | Director | P Buy | 2026-02-18 | 2026-02-20 | 10,658 | $17.48 | $186.3K | 10,658 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-13 | 2026-02-18 | 12,116 | $18.21 | $220.6K | 339,254 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-11 | 2026-02-12 | 241 | $18.00 | $4.3K | 351,370 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-10 | 2026-02-12 | 6,622 | $18.12 | $120.0K | 351,611 | SEC↗ |
| Garnett Timothy John | Director | P Buy | 2026-02-10 | 2026-02-12 | 14,124 | $17.89 | $252.7K | 14,124 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | A Award deriv | 2026-02-05 | 2026-02-09 | 93,955 | — | $0 | 93,955 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award deriv | 2026-02-05 | 2026-02-09 | 54,240 | — | $0 | 54,240 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award deriv | 2026-02-05 | 2026-02-09 | 31,395 | — | $0 | 31,395 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award deriv | 2026-02-05 | 2026-02-09 | 24,455 | — | $0 | 24,455 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award deriv | 2026-02-05 | 2026-02-09 | 31,395 | — | $0 | 31,395 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | A Award deriv | 2026-02-05 | 2026-02-09 | 31,395 | — | $0 | 31,395 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | A Award deriv | 2026-02-05 | 2026-02-09 | 24,455 | — | $0 | 24,455 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | A Award | 2026-02-05 | 2026-02-09 | 23,145 | — | $0 | 1,649,751 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award | 2026-02-05 | 2026-02-09 | 13,360 | — | $0 | 403,835 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award | 2026-02-05 | 2026-02-09 | 7,730 | — | $0 | 191,582 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award | 2026-02-05 | 2026-02-09 | 6,020 | — | $0 | 259,928 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award | 2026-02-05 | 2026-02-09 | 7,730 | — | $0 | 298,862 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | A Award | 2026-02-05 | 2026-02-09 | 7,730 | — | $0 | 395,549 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | A Award | 2026-02-05 | 2026-02-09 | 6,020 | — | $0 | 254,523 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-03 | 2026-02-04 | 1 | $18.00 | $18 | 358,233 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-02-02 | 2026-02-04 | 7,039 | $18.02 | $126.8K | 358,234 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-01-30 | 2026-01-30 | 6,612 | $18.11 | $119.7K | 365,273 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-01-29 | 2026-01-30 | 21,262 | $18.55 | $394.4K | 371,885 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-01-28 | 2026-01-30 | 5,860 | $18.61 | $109.1K | 393,811 | SEC↗ |
| Malenka Robert C. | Director | S Sale | 2026-01-28 | 2026-01-30 | 664 | $19.05 | $12.6K | 393,147 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 44,616 | $17.98 | $802.2K | 390,475 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | F Tax w/h | 2026-01-27 | 2026-01-29 | 22,050 | $17.98 | $396.5K | 248,503 | SEC↗ |
| Hanson Kristopher | General Counsel | F Tax w/h | 2026-01-27 | 2026-01-29 | 26,007 | $17.98 | $467.6K | 183,852 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 204,146 | $17.98 | $3.67M | 1,626,606 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 42,099 | $17.98 | $756.9K | 253,908 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 45,055 | $17.98 | $810.1K | 291,132 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 33,382 | $17.98 | $600.2K | 387,819 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | C Conversion deriv | 2025-10-28 | 2025-10-28 | 65,477 | — | $0 | 0 | SEC↗ |
| Malenka Robert C. | Director | C Conversion deriv | 2025-10-28 | 2025-10-28 | 65,477 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2025-10-28 | 2025-10-30 | 26,191,207 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2025-10-28 | 2025-10-30 | 19,734,671 | — | $0 | 0 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | C Conversion | 2025-10-28 | 2025-10-28 | 3,895 | — | $0 | 229,588 | SEC↗ |
| Malenka Robert C. | Director | C Conversion | 2025-10-28 | 2025-10-28 | 3,895 | — | $0 | 31,672 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion | 2025-10-28 | 2025-10-30 | 2,733,681 | — | $0 | 2,733,681 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2025-10-28 | 2025-10-30 | 952,941 | $17.00 | $16.20M | 3,686,622 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | A Award deriv | 2025-10-27 | 2025-10-28 | 916,164 | — | $0 | 916,164 | SEC↗ |
| Malenka Robert C. | Director | A Award deriv | 2025-10-27 | 2025-10-28 | 139,610 | — | $0 | 139,610 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award deriv | 2025-10-27 | 2025-10-28 | 196,035 | — | $0 | 196,035 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | A Award deriv | 2025-10-27 | 2025-10-28 | 176,031 | — | $0 | 176,031 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award deriv | 2025-10-27 | 2025-10-28 | 132,023 | — | $0 | 132,023 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award deriv | 2025-10-27 | 2025-10-28 | 146,052 | — | $0 | 146,052 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | A Award deriv | 2025-10-27 | 2025-10-28 | 124,022 | — | $0 | 124,022 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award deriv | 2025-10-27 | 2025-10-28 | 110,046 | — | $0 | 110,046 | SEC↗ |
| Walker Maria C | Director | A Award deriv | 2025-10-27 | 2025-10-28 | 25,604 | — | $0 | 25,604 | SEC↗ |
| Garnett Timothy John | Director | A Award deriv | 2025-10-27 | 2025-10-28 | 25,604 | — | $0 | 25,604 | SEC↗ |
| Kroeger Christopher A. | Chief Executive Officer | A Award | 2025-10-27 | 2025-10-28 | 225,693 | — | $0 | 225,693 | SEC↗ |
| Malenka Robert C. | Director | A Award | 2025-10-27 | 2025-10-28 | 34,390 | — | $0 | 399,671 | SEC↗ |
| Foff Erin Pennock | Chief Medical Officer | A Award | 2025-10-27 | 2025-10-28 | 48,275 | — | $0 | 48,275 | SEC↗ |
| Setia Vishwas | Chief Financial Officer | A Award | 2025-10-27 | 2025-10-28 | 43,367 | — | $0 | 43,367 | SEC↗ |
| Lillie James Woodruff | Chief Scientific Officer | A Award | 2025-10-27 | 2025-10-28 | 32,539 | — | $0 | 32,539 | SEC↗ |
| Kreitzer Anatol | Chief Discovery Officer | A Award | 2025-10-27 | 2025-10-28 | 35,953 | — | $0 | 35,953 | SEC↗ |
| GILLIS JONATHAN | CAAO and PAO | A Award | 2025-10-27 | 2025-10-28 | 30,565 | — | $0 | 30,565 | SEC↗ |
| Hanson Kristopher | General Counsel | A Award | 2025-10-27 | 2025-10-28 | 27,098 | — | $0 | 27,098 | SEC↗ |
| Walker Maria C | Director | A Award | 2025-10-27 | 2025-10-28 | 6,294 | — | $0 | 6,294 | SEC↗ |
| Garnett Timothy John | Director | A Award | 2025-10-27 | 2025-10-28 | 6,294 | — | $0 | 6,294 | SEC↗ |